Articles Posted in Mass Torts

Video game addiction lawsuits seek to hold gaming companies accountable for exploiting vulnerable players, particularly minors and young adults, through intentionally addictive game designs.

Gaming addiction has caused significant harm, including mental health struggles, social isolation, sleep disruption, academic decline, financial strain, and family conflict. The lawsuits allege that gaming companies prioritized profit over user safety by designing games to keep children and young adults playing longer, spending more money, and returning even when the games were harming them.

Our attorneys examine claims involving Fortnite, Roblox, Minecraft, Call of Duty, Grand Theft Auto, Apex Legends, Madden, FIFA, and other online games. Below, we look at who may qualify, the video game addiction settlement value our lawyers project for successful claims, and the latest developments in court.

Our lawyers are handling baby powder lawsuits in all 50 states in 2026. The talcum powder lawsuits against Johnson & Johnson have been ongoing for years. The lawsuits allege that prolonged use of talcum powder (or “talc”), the active ingredient in products such as Baby Powder and Shower to Shower, can cause ovarian cancer in some women.

This page provides an update on J&J talc powder litigation and discusses the settlement amounts in ovarian cancer lawsuits for victims.

Latest News on J&J Talc Powder Lawsuit Update 2026

Gabapentin lawsuits are now being filed over dementia, mild cognitive impairment, memory loss, and other serious cognitive problems. New research has raised concerns about a link between these injuries and long-term or repeated gabapentin use.

These cases are still developing, and we are in the early rounds of this. The deeper our lawyers dig into these cases, the more we believe in them.

Now, the litigation is starting to move forward. It seems the center of the litigation will be in state court in Philadelphia. A mass tort program for lawsuits involving gabapentin, sold as Neurontin, and pregabalin, sold as Lyrica, has been established there.

Our lawyers stopped accepting new Tylenol autism and ADHD cases after Judge Denise Cote excluded the plaintiffs’ causation experts, a ruling that led to the dismissal of the federal lawsuits.

There is now real reason for renewed optimism. In July 2026, the Second Circuit overturned the judgments resulting from Judge Cote’s expert testimony rulings. The defendants then asked the appeals court to reconsider, and, as we discuss below, that request has now been denied.

But our firm has not yet resumed accepting new Tylenol autism or ADHD claims. The appeals court did not decide that Tylenol causes autism or ADHD, and important questions about the expert evidence still have to be addressed on remand. We will continue following the litigation and reassess our position as the next steps become clearer.